Trial
NCT01480388
A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Active Rheumatoid Arthritis
Intervention
Placebo/JNJ-39758979 (300 mg/d)
Why stopped
Study was terminated prematurely due to 2 cases of agranulocytosis in a different clinical trial with this same drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-01